Table of Contents
Executive Summary
COVID-19 Epidemiology & Senior Vulnerability
Telehealth Adoption Acceleration
Medicare & Connected Health Regulatory Tailwinds
Senior Living Facility Crisis & Connected Health Imperative
Nursing Home Data Analysis
Market Demand Acceleration
CARES Act Funding Opportunities
Investment Thesis & Portfolio Implications
Executive Summary
The COVID-19 pandemic has created unprecedented tailwinds for connected health adoption among seniors. This analysis documents the epidemiology driving senior vulnerability, regulatory changes accelerating telehealth reimbursement, and resulting market opportunities for Salud Capital portfolio companies.
Key Insights:
Seniors (65+) account for 80% of COVID deaths despite being 16% of population
CMS expanded RPM reimbursement; waived prior authorization requirements; enabled telehealth payment parity
Medicare telehealth utilization increased 38x from pre-pandemic baseline (February to April 2020)
95,000+ nursing homes face acute monitoring crisis; connected health technology becomes operational necessity
HHS CARES Act funding ($175B) includes specific allocations for telehealth and remote monitoring infrastructure
COVID-19 Epidemiology & Senior Vulnerability
Seniors represent a disproportionately vulnerable population in pandemic:
Florida Case Data (March-July 2020)
Total Cases: 278,667 (confirmed as of July 2020)
Age 65+ Cases: 98,200 (35% of cases despite 21% of FL population)
Deaths (65+): 4,277 (confirmed deaths)
Case Fatality Rate (65+): 4.4% (vs. 0.5% for 25-44 age group)
CDC National Mortality Analysis
Age Group
% of Population
% of Deaths
Relative Risk
18-29
21%
1.3%
0.06x
30-39
14%
2.1%
0.15x
40-49
13%
4.2%
0.32x
50-64
18%
8.7%
0.48x
65-74
9%
16.5%
1.83x
75-84
5%
21.2%
4.24x
85+
2%
45.2%
22.6x
Salud Capital Research · July 2020 · Healthcare
Important disclosures
This report is published by Salud Capital LLC for informational purposes only. It is not investment advice, a recommendation, or an offer or solicitation to buy or sell any security, digital asset or other financial instrument, and it does not take into account the objectives, financial situation or needs of any reader.
Information in this report is drawn from sources believed to be reliable, but Salud Capital makes no representation or warranty as to its accuracy or completeness. Opinions, estimates and forward-looking statements reflect judgment as of the report date, may change without notice and may not be realized. Salud Capital has no obligation to update this report. Past performance is not indicative of future results.
Salud Capital, its principals and affiliates may hold positions in, or have business relationships with, companies or assets discussed in this report. Readers should conduct their own due diligence and consult their own legal, tax and financial advisers before making any decision.
© 2020 Salud Capital LLC. All rights reserved.
· Salud Capital
· All research
· Healthcare